Icure Pharmaceutical Incorporation (KOSDAQ:175250)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025

KOSDAQ:175250 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
81,09281,09267,82678,10379,498338,828
Market Cap Growth
-2.03%19.56%-13.16%-1.75%-76.54%-27.50%
Enterprise Value
115,356116,15686,382142,444141,972399,730
Last Close Price
2170.002170.001815.002090.002555.0013038.48
PE Ratio
--56.63---
Forward PE
-7.877.877.877.877.87
PS Ratio
0.970.971.341.381.345.27
PB Ratio
2.952.951.101.300.873.43
P/TBV Ratio
3.133.131.231.530.953.83
EV/Sales Ratio
1.381.391.702.512.396.22
Debt / Equity Ratio
1.001.000.661.230.950.75
Net Debt / Equity Ratio
0.610.610.291.090.360.50
Net Debt / EBITDA Ratio
-1.44-1.44-2.51-3.53-1.76-2.23
Net Debt / FCF Ratio
-2.13-2.13-0.94-4.16-2.15-1.56
Asset Turnover
0.740.740.340.290.270.31
Inventory Turnover
7.247.243.404.714.724.75
Quick Ratio
0.440.440.530.180.570.66
Current Ratio
0.620.620.760.330.731.07
Return on Equity (ROE)
-79.17%-79.17%5.76%-42.30%-44.66%-35.97%
Return on Assets (ROA)
-10.22%-10.22%-6.64%-8.83%-7.70%-9.17%
Return on Invested Capital (ROIC)
-29.24%-29.60%-15.56%-22.02%-19.80%-19.54%
Return on Capital Employed (ROCE)
-52.30%-52.30%-23.00%-37.40%-23.70%-18.80%
Earnings Yield
-41.43%-41.43%1.77%-40.04%-52.54%-11.26%
FCF Yield
-9.61%-9.61%-28.13%-20.16%-19.47%-9.42%
Buyback Yield / Dilution
-0.09%-0.09%0.35%-61.23%-7.58%-9.71%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.